Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Custom Monoclonal Antibody Production | Biorbyt
Custom Monoclonal Antibody Production Banner
 

Custom Monoclonal Antibody Production

Monoclonal antibodies from Biorbyt are generated from identical immune cell clones originating from a single parent hybridoma cell, yielding exceptional epitope specificity and batch-to-batch consistency compared to polyclonal antibodies. Biorbyt delivers reliable, custom-engineered monoclonal antibody development tailored to support target validation, assay development, and diagnostic research.

Advantages of Biorbyt's Monoclonal Antibodies

Exceptional Quality Control

Biorbyt maintains strict quality assurance standards throughout production, guaranteeing that every monoclonal antibody lot meets rigorous benchmarks for purity, specificity, and functional performance.

Customization Options

Our custom monoclonal development services allow you to tailor key antibody characteristics—including target epitope specificity, immunoglobulin isotype, host species, and formulation buffers—to your exact experimental requirements.

Large-Scale Biomanufacturing

With extensive bioprocessing expertise, Biorbyt efficiently scales hybridoma clone expansion and antibody purification to supply bulk gram-scale quantities for high-throughput diagnostic and industrial applications.

Comprehensive Screening & Validation

Every generated hybridoma clone undergoes multi-tier functional screening (ELISA, Western Blot) to ensure high binding affinity, robust stability, and long-term cell line viability.

Custom Monoclonal Antibody Production Process Flowchart

Service Process & Deliverables

Peptide Immunogen

Lead Time: 20 – 25 Weeks

Recombinant Protein

Lead Time: 20 – 25 Weeks

Native Protein

Lead Time: 20 – 25 Weeks

Workflow Process

  1. Antigen preparation & quality evaluation
  2. Host animal immunization protocol
  3. Serum titer detection & splenocyte fusion
  4. Hybridoma screening & subcloning
  5. Affinity or Protein A/G chromatography purification
  6. Western Blot (WB) validation with target antigen

Key Deliverables

  • Comprehensive Quality Control (QC) report for immunogen target
  • 100 µL ascites fluid or purified antibody sample
  • Guaranteed ELISA titer threshold of 1:10,000
  • Guaranteed Western Blot (WB) positive validation against antigen
  • Detailed hybridoma validation report
  • Additional application validation available upon request (IHC, IF, IP, Flow Cytometry)
 

*By pressing "SUBMIT" you are agreeing to Biorbyt storing the information provided and contacting you in line with our privacy policy.

Please reach out to us at [email protected] to discuss your request for . Our scientists are here to answer your questions and provide you with the information and expertise you need for your projects.